Pharma Journalist -

Sanofi celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital facilities using intensified,…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a…
Read More...

SMi Reports: Agenda and speaker overview of the upcoming 4th Annual 3D Cell Culture Conference 2020, in London. SMi Group is delighted to announce the return of the successful 3D…
Read More...

SOTIO, together with PPF, and MaveriX Oncology, Inc., announce the investment of PPF Group in MaveriX Oncology Inc., a private biotech company with a proprietary pipeline of targeted,…
Read More...

CombiGene AB (publ) signed an agreement with the Anglo-Swedish Contract Development and Manufacturing Organisation (CDMO) Cobra Biologics for production of candidate drug CG01. The…
Read More...

PharmaCyte Biotech, a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box,…
Read More...

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety and…
Read More...

Pharmaceutical and biopharmaceutical manufacturers can now verify the identity of ionic salts in the warehouse in a matter of seconds with a new portable X-ray fluorescence (XRF)…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved XARELTO (rivaroxaban) for the prevention of venous…
Read More...

Gilead Sciences, Inc. and Galapagos NV  announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of filgotinib, an investigational, oral, selective JAK1…
Read More...